NASH, acute Liver Failure and Comlications of Liver Cirrhosis Non-Alcoholic Steatohepatitis (NASH) - of the Pathophysiology of innovative Treatment

被引：0
|
作者：
Tilg, Herbert [1 ,2 ]
机构：
[1] Med Univ Innsbruck, Abt Innere Med, Innsbruck, Austria
[2] Med Univ Innsbruck, Christian Doppler Forsch Lab Entzundungsbiol, Innsbruck, Austria
来源：
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2010年 / 60卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：713 / 714
页数：2
相关论文
共 50 条
  • [31] A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
    Sekhon, Anupamjeet Kaur
    Gollapalli, Aniruddha
    Kaur, Dharamjeet
    Janssen, Bryan
    Stevens, Mark L.
    Valerio, Fernando
    Sierra-Hoffman, Miguel A.
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [32] Sorafenib improves liver mitochondrial dysfunction attenuating liver fibrosis in non-alcoholic steatohepatitis (NASH) model
    Stefano, Jose Tadeu
    Pereira, Isabel V.
    Coelho, Ana Maria M.
    Xerfan, Mariana P.
    Barbeiro, Denise F.
    Torres, Mariana Maciel
    Bida, Patricia Martins
    Mazo, Daniel F.
    Cogliati, Bruno
    Souza, Heraldo Possolo
    D'Albuquerque, Luiz C.
    Carrilho, Flair J.
    Oliveira, Claudia P.
    HEPATOLOGY, 2012, 56 : 864A - 864A
  • [33] Iron potentiates liver injury in the rat nutritional model of non-alcoholic steatohepatitis (NASH)
    Kirsch, R
    Verdonk, RV
    Twala, M
    Valashiya, C
    De Vries, A
    Shephard, EG
    Kirsch, RE
    Hall, PD
    JOURNAL OF HEPATOLOGY, 2002, 36 : 148 - 148
  • [34] PRESENCE OF LIVER ANGIOGENESIS AND UPREGULATION OF VEGF IN A MICE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Coulon, Stephanie H.
    Geerts, Anja M.
    Casteleyn, Christophe
    Heindryckx, Femke
    Van Steenkiste, Christophe
    Libbrecht, Louis
    Van Vlierberghe, Hans
    Colle, Isabelle
    HEPATOLOGY, 2010, 52 (04) : 1062A - 1063A
  • [35] Effects of pentoxifylline and weight reduction on liver histology in patients with non-alcoholic steatohepatitis (NASH)
    Kumar, Ajay
    Kumar, Ashish
    Sakhuja, Puja
    Singh, Deepak K.
    Sharma, Barjesh C.
    Sarin, Shiv K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S236 - S236
  • [36] Non-alcoholic steatohepatitis (NASH)-related cirrhosis is not associated with lower patient eligibility for liver transplantation compared to other liver disease aetiologies
    Koutli, Evangelia
    Mantovani, Anna
    Marshall, Aileen
    Ryan, Jennifer
    Westbrook, Rachel
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S11 - S12
  • [37] Non alcoholic steatohepatitis (NASH) sensitizes liver to hepatotoxicity.
    Donthamsetty, S
    Bhave, VS
    Mitra, MS
    Latendresse, JR
    Mehendale, HM
    HEPATOLOGY, 2005, 42 (04) : 631A - 631A
  • [38] FAT Score, A novel predictive score to differentiate Non-alcoholic steatohepatitis (NASH) from Non alcoholic fatty liver disease without NASH
    Varghese, Jijo
    Devadas, Krishnadas
    Maniyalath, Narendranathan
    Prasanth, S.
    Nahaz, Nibin
    Thomas, David
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 515 - 515
  • [39] Current and future treatment options in non-alcoholic steatohepatitis (NASH)
    Lazaridis, Nikos
    Tsochatzis, Emmanuel
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (04) : 357 - 369
  • [40] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
    Cuadrado, A
    Orive, A
    García-Suárez, C
    Domínguez, A
    Fernández-Escalante, JC
    Crespo, J
    Pons-Romero, F
    OBESITY SURGERY, 2005, 15 (03) : 442 - 446
12345